| Entry |
|
|---|
| Name |
Uracil mustard (USAN);
Uramustine (INN);
Uracil mustard (TN) |
|---|
| Formula |
C8H11Cl2N3O2
|
|---|
| Exact mass |
251.0228
|
|---|
| Mol weight |
252.0978
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG01677 Alkylating agent
DG01678 Nitrogen mustard analog
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Target |
DNA |
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AD Nitrosoureas
L01AD08 Uramustine
D06265 Uracil mustard (USAN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01678 Nitrogen mustard analog
D06265 Uracil mustard
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 15
1 C8y C 30.1613 -20.0918
2 C8x C 30.1730 -21.4906
3 C8y C 31.3736 -19.3982
4 N4x N 31.3736 -22.1958
5 N4x N 32.5917 -20.0918
6 O5x O 31.3852 -17.9936
7 C8y C 32.5917 -21.4964
8 O5x O 33.8041 -22.1899
9 N1c N 28.9522 -19.3974
10 C1b C 28.9488 -17.9843
11 C1b C 27.7419 -20.1000
12 C1b C 30.1801 -17.2691
13 X Cl 30.1801 -15.8691
14 C1b C 27.7450 -21.4898
15 X Cl 26.5155 -22.2035
BOND 15
1 7 8 2
2 5 7 1
3 1 9 1
4 1 2 2
5 1 3 1
6 2 4 1
7 3 5 1
8 3 6 2
9 4 7 1
10 9 10 1
11 9 11 1
12 10 12 1
13 12 13 1
14 11 14 1
15 14 15 1
|
|---|
